Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar and CHOPT for T Cell Lymphoma
NCT01430013Phase 2Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jun 2011
- Primary completion
- Nov 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in T-cell lymphoma, sponsored by Tianjin Medical University Cancer Institute and Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
T-cell lymphoma
Beyond the preview
Go deeper on NCT01430013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430013.